Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target ; volume:21 ; number:1 ; day:20 ; month:2 ; year:2023 ; pages:1-3 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (20.2.2023), 1-3, 12.2023
- Creator
-
Ouyang, Zhengxiao
Wang, Sisi
Zeng, Ming
Li, Zhihong
Zhang, Qing
Wang, Wanchun
Liu, Tang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01046-y
- URN
-
urn:nbn:de:101:1-2023042621050402093631
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ouyang, Zhengxiao
- Wang, Sisi
- Zeng, Ming
- Li, Zhihong
- Zhang, Qing
- Wang, Wanchun
- Liu, Tang
- SpringerLink (Online service)
Other Objects (12)
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling